WINVEST GROUP SUBSIDIARY IQI MEDIA PARTNERS WITH BIOCALTH TO DRIVE DIRECT-TO-CONSUMER SALES

Rhea-AI Summary

Winvest Group Limited (OTCQB: WNLV) announced that its subsidiary IQI Media has formed a strategic partnership with BioCalth International, a health supplement manufacturer. The partnership involves a content management agreement with profit-sharing incentives, including a fixed monthly retainer and percentage-based profit sharing when net revenue reaches $30,000 to $1,000,000+.

IQI Media will support BioCalth's first e-commerce launch and market their flagship calcium L-threonate product, which boasts a 95% absorption rate verified through UCLA research. Additionally, BioCalth is expanding its FDA-registered and GMP-certified California manufacturing facility to provide services to pharmaceutical and nutritional supplement companies.

Positive

• Partnership includes fixed monthly retainer plus profit-sharing incentives
• BioCalth's flagship product shows 95% absorption rate in UCLA research
• Expansion of FDA-registered and GMP-certified manufacturing facility
• New revenue stream through manufacturing services for other companies

Negative

• Revenue sharing only triggers after reaching $30,000 in net revenue
• Entering competitive direct-to-consumer supplement market with new e-commerce initiative

News Market Reaction – WNLV

-15.57%

1 alert

-15.57% News Effect

On the day this news was published, WNLV declined 15.57%, reflecting a significant negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

RENO, Nev., Aug. 22, 2025 /PRNewswire/ -- Winvest Group Limited (OTCQB: WNLV) ("Winvest"), an investment holding company with diverse media, entertainment, and technology portfolios, is pleased to announced that its subsidiary IQI Media Inc. has partnered with BioCalth International Inc., a world leader in the development of proprietary health supplements, to help BioCalth grow its direct-to-consumer sales.

The two companies have entered into a content management agreement with profit-sharing incentives that they hope will lead to a long-term relationship marked by increased revenue and brand recognition for BioCalth. The agreement offers IQI Media a fixed monthly retainer as well as a percentage of the profit margin once total net revenue from conversions reaches $30,000 to $1,000,000+.

"BioCalth has been a prominent player in the supplement industry for over 25 years, manufacturing their patented products here in the USA while exporting them globally through various retailers," said Khiow Hui Lim, Founder of IQI Media. "We're excited to support BioCalth in launching their first ecommerce store and introducing calcium L-threonate—their flagship product backed by three patents—to a new generation of health-conscious consumers.

As part of the launch, IQI will be working to help BioCalth's products gain traction through a top-of-funnel (TOFU) strategy for social marketing that builds awareness and trust. "BioCalth has conducted extensive laboratory research at UCLA, scientifically verifying that our calcium L-threonate formula has a 95% absorption rate," said Jackson Wen, Founder of BioCalth. "With the help of IQI, we can get the word out about how our clinically proven product is better absorbed by the body than almost any other calcium supplement."

In addition to kicking off direct-to-consumer sales and social marketing that targets audiences focused on self-care and bone density, BioCalth is also expanding its manufacturing pipeline at its state-of-the-art California plant by providing manufacturing services to others, including pharmaceutical and nutritional supplement companies. The FDA-registered and GMP-certified (Good Manufacturing Practice) facility utilizes newly installed automation intelligence equipment to maintain the highest standards of safety and reliability.

"Initiating this new phase of expansion involves integrating sales, data analytics, and backend management," said Sophia Li, VP of Marketing at BioCalth. "It also serves as the core strategy for BioCalth's future growth, ensuring both healthy development and steady progress. We intend to bolster our standing as a GMP manufacturer that sets the bar in biotechnology production."

About IQI Media:

Headquartered in Los Angeles, California, IQI Media Inc. is a subsidiary of Winvest Group Limited (OTCQB: WNLV), a publicly traded investment holding company. IQI Media produces and manages original content while also providing creative and cost-effective content marketing services for clients seeking data-driven growth.

About BioCalth:

Founded in 2000, BioCalth International Inc. is a science-based wellness company based in La Verne, California, just east of Los Angeles. Combining scientifically validated natural ingredients with advanced technology, BioCalth strives to help its customers take control of their health. The company's recently launched ecommerce site can be found at https://biocalth.us/.

About Winvest:

Headquartered in Reno, Nevada, Winvest Group Limited is an investment holding company focused on media, entertainment, and technology. Shares in the company are currently traded on the OTC Markets (QB tier) under the stock ticker "WNLV," with plans to upgrade to Nasdaq and pursue an IPO in the near future.

View original content to download multimedia:https://www.prnewswire.com/news-releases/winvest-group-subsidiary-iqi-media-partners-with-biocalth-to-drive-direct-to-consumer-sales-302535361.html

SOURCE Winvest Group Ltd

FAQ

What is the partnership between Winvest Group's IQI Media and BioCalth?

IQI Media will manage BioCalth's content and e-commerce launch with a profit-sharing agreement that includes a fixed monthly retainer and percentage-based profit sharing for revenues between $30,000 to $1,000,000+.

What is BioCalth's main product and its effectiveness?

BioCalth's flagship product is calcium L-threonate, which has three patents and demonstrated a 95% absorption rate in UCLA laboratory research.

How is BioCalth expanding its manufacturing capabilities?

BioCalth is expanding its FDA-registered and GMP-certified California facility with automation intelligence equipment to provide manufacturing services to pharmaceutical and nutritional supplement companies.

What is IQI Media's marketing strategy for BioCalth products?

IQI Media will implement a top-of-funnel (TOFU) social marketing strategy targeting health-conscious consumers, focusing on building awareness and trust for BioCalth's products.

What are the revenue sharing terms in the WNLV-BioCalth partnership?

The agreement includes a fixed monthly retainer and profit margin percentage once total net revenue from conversions reaches between $30,000 to $1,000,000+.